A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Neoadjuvant chemotherapy (NAC) is widely used as a standard treatment for early-stage triple-negative breast cancer (TNBC). While patients who achieve pathologic complete response (pCR) have a highly favorable outcome, patients who do not achieve pCR have variable prognoses. It is important to ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Hae Hyun, Kim, Ji-Yeon, Cho, Eun Yoon, Lee, Jeong Eon, Kim, Seok Won, Nam, Seok Jin, Park, Yeon Hee, Ahn, Jin Seok, Im, Young-Hyuck
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647725/
https://www.ncbi.nlm.nih.gov/pubmed/37958571
http://dx.doi.org/10.3390/ijms242115576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647725/
https://www.ncbi.nlm.nih.gov/pubmed/37958571
http://dx.doi.org/10.3390/ijms242115576

Ejemplares similares